Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study.
Research article published in Scientific reports (2025)
Abstract
DOACs are widely used for stroke prevention in non-valvular atrial fibrillation and treatment of thromboembolism, but gaps in their management can lead to adverse outcomes. In outpatient, underserved clinics, challenges such as inappropriate dosing, lack of monitoring, and improper drug combinations may be more pronounced, necessitating evaluation to optimize patient care and reduce risks. This study assessed the appropriateness of DOAC use and dosing per FDA guidelines, considering renal function, hepatic function, and drug-drug interactions. Secondary objectives focused on evaluating inappropriate aspirin use alongside DOACs. This was a single-center retrospective cohort study. The study was conducted at Texas A&M Health Family Care Clinic (12/24/2022-12/24/2023). Older than 18 years of age and had active prescription of DOAC (apixaban, dabigatran, edoxaban, or rivaroxaban). A total of 125 DOAC patients were included. Inappropriate dosing based on renal function occurred in 16% of cases. DOAC use was unsuitable in two patients with severe hepatic impairment. Major drug interactions resulted in two instances of inappropriate DOAC use. Additionally, about 61% of aspirin usage involved inappropriate combinations with DOACs, as shown in Fig. 1. The study's findings indicate that anticoagulation management in our ambulatory care setting has the potential for further optimization.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study.
Por qué esto importa para la hirudoterapia
Esta cohorte retrospectiva unicéntrica de 125 pacientes con DOAC en una clínica ambulatoria desatendida encontró brechas de manejo medibles: dosificación inapropiada basada en la función renal en el 16% de los casos, uso inadecuado en insuficiencia hepática grave, errores importantes de interacciones farmacológicas y combinaciones inapropiadas de aspirina con DOAC en aproximadamente el 61% de los usuarios de aspirina. Para la ASH, esto documenta la fragilidad en el mundo real del manejo anticoagulante sistémico, las cargas de dosificación, monitoreo e interacciones que la anticoagulación local basada en sanguijuelas no impone, al mismo tiempo que refuerza que cualquier estrategia anticoagulante exige una supervisión cuidadosa. Como una auditoría retrospectiva pequeña y unicéntrica, describe la calidad de la práctica en un solo sitio y no puede generalizarse; concierne solo a agentes orales y no tiene relación con la eficacia o seguridad de la hirudoterapia.
Citación
Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study.
Alghamdi et al. · Scientific reports, 2025
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026